DYNAVAX TECHNOLOGIES CORP SEC Filings

Filed On	Filing
20 Feb 2026	15-12G
13 Feb 2026	EFFECT
11 Feb 2026	Form 4: Deep Track Biotechnology Master Fund, Ltd., 10% owner and 2 others Disposed of 15,726,349 shares (Tender Offer)
11 Feb 2026	SCHEDULE 13G/A
10 Feb 2026	S-8 POS
10 Feb 2026	S-8 POS
10 Feb 2026	S-8 POS
10 Feb 2026	S-8 POS
10 Feb 2026	S-8 POS
10 Feb 2026	S-8 POS
10 Feb 2026	S-8 POS
10 Feb 2026	S-8 POS
10 Feb 2026	S-8 POS
10 Feb 2026	Form 4: Spencer Ryan, Director Disposed of 379,620 shares (Tender Offer) · Received 301,000 shares as a grant or award · Returned 301,000 shares to the issuer · 2 more
10 Feb 2026	S-8 POS
10 Feb 2026	Form 4: Slebir John L, SVP General Counsel Disposed of 69,634 shares (Tender Offer) · Received 92,424 shares as a grant or award · Returned 92,424 shares to the issuer · 2 more
10 Feb 2026	Form 4: Metzinger Joseph Anthony, VP, Chief Accounting Officer Disposed of 7,129 shares (Tender Offer) · Disposed of 31,500 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 25,455 Restricted Stock Units (Disposition to Issuer)
10 Feb 2026	Form 4: MacDonald Kelly, SVP and CFO Disposed of 60,204 shares (Tender Offer) · Received 88,854 shares as a grant or award · Returned 88,854 shares to the issuer · 2 more
10 Feb 2026	Form 4: Emini Emilio, Director Returned 10,075 shares to the issuer · Disposed of 49,875 Stock Option (Right to Buy) (Disposition to Issuer)
10 Feb 2026	Form 4: Myers Scott Dunseth, Director Disposed of 3,800 shares (Tender Offer) · Returned 31,204 shares to the issuer · Disposed of 135,375 Stock Option (Right to Buy) (Disposition to Issuer)

Comments